NCT03897309: Safety & Immunogenicity Study of Ad5 Based Oral Norovirus Vaccines
- State
- Completed
- Phase
- Phase 1
- People
- 86 taking part
- Started
- 20 Mar 2019
- Primary completion
- 15 Jan 2021
- Arms
- Bivalent GI.1 and GII.4 vaccine group
- Results
- None posted
- 20 Mar 2019: Trial started
- 1 Apr 2019: Trial registered
- 1 Apr 2021: Trial completed